Audentes Therapeutics, Inc. - 10%+ Owner at Taysha Gene Therapies, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
TSHA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Audentes Therapeutics, Inc. since 15 Mar 2025

Holdings reported by Audentes Therapeutics, Inc. for Taysha Gene Therapies, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,266,342 $11,844,137 $1.63 21 Oct 2022 Direct

There are no transactions reported by Audentes Therapeutics, Inc. for Taysha Gene Therapies, Inc.